The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice
- PMID: 4788032
- PMCID: PMC1776598
- DOI: 10.1111/j.1476-5381.1973.tb08534.x
The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice
Abstract
1. After oral administration to mice, pethidine, Delta(8)-tetrahydrocannabinol (THC), Delta(9)-THC, a cannabis extract and cannabinol had a dose-dependent antinociceptive effect when measured by the hot-plate method. Cannabidiol was inactive at 30 mg/kg. Delta(8)-THC, Delta(9)-THC and pethidine did not differ significantly in potency, but Delta(9)-THC was 6.5 times more active than cannabinol.2. After oral administration, three different cannabis extracts, Delta(8)-THC, Delta(9)-THC and morphine produced dose-dependent depressions of the passage of a charcoal meal in mice. Delta(8)-THC and Delta(9)-THC were equipotent and were about five times less potent than morphine. Cannabidiol was inactive up to 30 mg/kg. The effect of the three cannabis extracts on intestinal motility could be accounted for by their Delta(9)-THC content.3. The antinociceptive effect of pethidine and the effect of morphine on intestinal motility were antagonized by nalorphine whilst the effects of the cannabis extracts and the pure cannabinoids were not.4. From these results it is concluded that although cannabis and the narcotics share several common pharmacological properties, the mode of action of each is pharmacologically distinct.
Similar articles
-
Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats.Psychopharmacologia. 1975;40(4):285-95. doi: 10.1007/BF00421466. Psychopharmacologia. 1975. PMID: 1170585
-
The interaction between prostaglandin E1 and delta 9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse.Psychopharmacologia. 1976 May 28;47(2):187-93. doi: 10.1007/BF00735820. Psychopharmacologia. 1976. PMID: 1273216
-
A pharmacological characterization of Cannabis sativa chemovar extracts.J Cannabis Res. 2020 May 11;2(1):17. doi: 10.1186/s42238-020-00026-0. J Cannabis Res. 2020. PMID: 33526117 Free PMC article.
-
The biochemical pharmacology of abused drugs. III. Cannabis, opiates, and synthetic narcotics.Clin Pharmacol Ther. 1974 Dec;16(6):989-1013. doi: 10.1002/cpt1974166989. Clin Pharmacol Ther. 1974. PMID: 4154773 Review. No abstract available.
-
Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.Curr Pharm Des. 2000 Sep;6(13):1339-45. doi: 10.2174/1381612003399473. Curr Pharm Des. 2000. PMID: 10903396 Review.
Cited by
-
The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Neurogastroenterol Motil. 2016 Dec;28(12):1765-1780. doi: 10.1111/nmo.12931. Epub 2016 Aug 26. Neurogastroenterol Motil. 2016. PMID: 27561826 Free PMC article. Review.
-
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review.Pain. 2020 Feb;161(2):244-260. doi: 10.1097/j.pain.0000000000001720. Pain. 2020. PMID: 31613869 Free PMC article.
-
The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.Psychopharmacology (Berl). 1979 Mar 22;61(2):207-16. doi: 10.1007/BF00426738. Psychopharmacology (Berl). 1979. PMID: 86997
-
Cannabinoids and the gastrointestinal tract.Gut. 2001 Jun;48(6):859-67. doi: 10.1136/gut.48.6.859. Gut. 2001. PMID: 11358910 Free PMC article. Review.
-
Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.Int J Mol Sci. 2021 Dec 22;23(1):94. doi: 10.3390/ijms23010094. Int J Mol Sci. 2021. PMID: 35008517 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources